nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—Dactinomycin—sarcoma	0.103	0.289	CbGbCtD
Cilazapril—ABCB1—Mitoxantrone—sarcoma	0.0923	0.259	CbGbCtD
Cilazapril—ABCB1—Vincristine—sarcoma	0.0635	0.178	CbGbCtD
Cilazapril—ABCB1—Etoposide—sarcoma	0.0582	0.163	CbGbCtD
Cilazapril—ABCB1—Doxorubicin—sarcoma	0.0397	0.111	CbGbCtD
Cilazapril—ACE—forelimb zeugopod—sarcoma	0.0329	0.166	CbGeAlD
Cilazapril—ACE—pulmonary artery—sarcoma	0.0246	0.125	CbGeAlD
Cilazapril—ACE—forelimb—sarcoma	0.0165	0.0837	CbGeAlD
Cilazapril—ACE—umbilical vein—sarcoma	0.0162	0.0823	CbGeAlD
Cilazapril—ACE—hindlimb—sarcoma	0.0149	0.0753	CbGeAlD
Cilazapril—ACE—arm—sarcoma	0.0142	0.0719	CbGeAlD
Cilazapril—ACE—appendage—sarcoma	0.0128	0.0646	CbGeAlD
Cilazapril—ACE—endothelium—sarcoma	0.0077	0.039	CbGeAlD
Cilazapril—SLC15A2—mammary gland—sarcoma	0.00541	0.0274	CbGeAlD
Cilazapril—ACE—embryo—sarcoma	0.00423	0.0215	CbGeAlD
Cilazapril—ACE—seminal vesicle—sarcoma	0.00398	0.0201	CbGeAlD
Cilazapril—ACE—hematopoietic system—sarcoma	0.00378	0.0191	CbGeAlD
Cilazapril—ACE—connective tissue—sarcoma	0.00364	0.0184	CbGeAlD
Cilazapril—SLC15A2—seminal vesicle—sarcoma	0.00347	0.0176	CbGeAlD
Cilazapril—ACE—smooth muscle tissue—sarcoma	0.00333	0.0169	CbGeAlD
Cilazapril—ACE—cardiac atrium—sarcoma	0.00287	0.0145	CbGeAlD
Cilazapril—SLC15A1—liver—sarcoma	0.00273	0.0138	CbGeAlD
Cilazapril—ACE—lymphoid tissue—sarcoma	0.00266	0.0135	CbGeAlD
Cilazapril—ACE—bone marrow—sarcoma	0.00242	0.0123	CbGeAlD
Cilazapril—ACE—testis—sarcoma	0.00207	0.0105	CbGeAlD
Cilazapril—ACE—liver—sarcoma	0.00196	0.00992	CbGeAlD
Cilazapril—SLC15A2—testis—sarcoma	0.00181	0.00915	CbGeAlD
Cilazapril—ABCB1—myometrium—sarcoma	0.00155	0.00785	CbGeAlD
Cilazapril—ACE—lymph node—sarcoma	0.0015	0.00761	CbGeAlD
Cilazapril—ABCB1—embryo—sarcoma	0.00149	0.00755	CbGeAlD
Cilazapril—ABCB1—seminal vesicle—sarcoma	0.0014	0.00709	CbGeAlD
Cilazapril—ABCB1—hematopoietic system—sarcoma	0.00133	0.00674	CbGeAlD
Cilazapril—SLC15A2—lymph node—sarcoma	0.00131	0.00663	CbGeAlD
Cilazapril—ABCB1—uterus—sarcoma	0.00101	0.00509	CbGeAlD
Cilazapril—ABCB1—lymphoid tissue—sarcoma	0.000937	0.00475	CbGeAlD
Cilazapril—ABCB1—bone marrow—sarcoma	0.000853	0.00432	CbGeAlD
Cilazapril—ABCB1—testis—sarcoma	0.000729	0.00369	CbGeAlD
Cilazapril—Pain—Mitoxantrone—sarcoma	0.000703	0.00158	CcSEcCtD
Cilazapril—Constipation—Mitoxantrone—sarcoma	0.000703	0.00158	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000703	0.00158	CcSEcCtD
Cilazapril—Hypersensitivity—Thiotepa—sarcoma	0.000702	0.00157	CcSEcCtD
Cilazapril—Face oedema—Doxorubicin—sarcoma	0.000697	0.00156	CcSEcCtD
Cilazapril—Hypersensitivity—Dactinomycin—sarcoma	0.000697	0.00156	CcSEcCtD
Cilazapril—Gastrointestinal pain—Vincristine—sarcoma	0.000691	0.00155	CcSEcCtD
Cilazapril—Confusional state—Etoposide—sarcoma	0.00069	0.00155	CcSEcCtD
Cilazapril—ABCB1—liver—sarcoma	0.000689	0.00349	CbGeAlD
Cilazapril—Asthenia—Thiotepa—sarcoma	0.000683	0.00153	CcSEcCtD
Cilazapril—Ataxia—Doxorubicin—sarcoma	0.000679	0.00152	CcSEcCtD
Cilazapril—Asthenia—Dactinomycin—sarcoma	0.000678	0.00152	CcSEcCtD
Cilazapril—Feeling abnormal—Mitoxantrone—sarcoma	0.000678	0.00152	CcSEcCtD
Cilazapril—Pruritus—Thiotepa—sarcoma	0.000674	0.00151	CcSEcCtD
Cilazapril—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000673	0.00151	CcSEcCtD
Cilazapril—Thrombocytopenia—Etoposide—sarcoma	0.00067	0.0015	CcSEcCtD
Cilazapril—Tachycardia—Etoposide—sarcoma	0.000668	0.0015	CcSEcCtD
Cilazapril—Abdominal pain—Vincristine—sarcoma	0.000668	0.0015	CcSEcCtD
Cilazapril—Liver function test abnormal—Doxorubicin—sarcoma	0.000667	0.0015	CcSEcCtD
Cilazapril—Skin disorder—Etoposide—sarcoma	0.000665	0.00149	CcSEcCtD
Cilazapril—Hyperhidrosis—Etoposide—sarcoma	0.000661	0.00148	CcSEcCtD
Cilazapril—Pancreatitis—Epirubicin—sarcoma	0.000661	0.00148	CcSEcCtD
Cilazapril—Orthostatic hypotension—Doxorubicin—sarcoma	0.000659	0.00148	CcSEcCtD
Cilazapril—Angina pectoris—Epirubicin—sarcoma	0.000657	0.00147	CcSEcCtD
Cilazapril—Urticaria—Mitoxantrone—sarcoma	0.000653	0.00147	CcSEcCtD
Cilazapril—Anorexia—Etoposide—sarcoma	0.000652	0.00146	CcSEcCtD
Cilazapril—Diarrhoea—Thiotepa—sarcoma	0.000652	0.00146	CcSEcCtD
Cilazapril—Abdominal pain—Mitoxantrone—sarcoma	0.00065	0.00146	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00065	0.00146	CcSEcCtD
Cilazapril—Bronchitis—Epirubicin—sarcoma	0.000649	0.00145	CcSEcCtD
Cilazapril—Diarrhoea—Dactinomycin—sarcoma	0.000647	0.00145	CcSEcCtD
Cilazapril—Hypotension—Etoposide—sarcoma	0.000639	0.00143	CcSEcCtD
Cilazapril—Neutropenia—Epirubicin—sarcoma	0.000631	0.00141	CcSEcCtD
Cilazapril—Dysuria—Epirubicin—sarcoma	0.000631	0.00141	CcSEcCtD
Cilazapril—Dizziness—Thiotepa—sarcoma	0.00063	0.00141	CcSEcCtD
Cilazapril—Pollakiuria—Epirubicin—sarcoma	0.000623	0.0014	CcSEcCtD
Cilazapril—Hypersensitivity—Vincristine—sarcoma	0.000622	0.0014	CcSEcCtD
Cilazapril—Photosensitivity reaction—Epirubicin—sarcoma	0.000616	0.00138	CcSEcCtD
Cilazapril—Paraesthesia—Etoposide—sarcoma	0.000614	0.00138	CcSEcCtD
Cilazapril—Pancreatitis—Doxorubicin—sarcoma	0.000612	0.00137	CcSEcCtD
Cilazapril—Dyspnoea—Etoposide—sarcoma	0.00061	0.00137	CcSEcCtD
Cilazapril—Hyperglycaemia—Epirubicin—sarcoma	0.000608	0.00136	CcSEcCtD
Cilazapril—Somnolence—Etoposide—sarcoma	0.000608	0.00136	CcSEcCtD
Cilazapril—Angina pectoris—Doxorubicin—sarcoma	0.000608	0.00136	CcSEcCtD
Cilazapril—Hypersensitivity—Mitoxantrone—sarcoma	0.000606	0.00136	CcSEcCtD
Cilazapril—Asthenia—Vincristine—sarcoma	0.000606	0.00136	CcSEcCtD
Cilazapril—Vomiting—Thiotepa—sarcoma	0.000606	0.00136	CcSEcCtD
Cilazapril—Vomiting—Dactinomycin—sarcoma	0.000601	0.00135	CcSEcCtD
Cilazapril—Rash—Thiotepa—sarcoma	0.000601	0.00135	CcSEcCtD
Cilazapril—Bronchitis—Doxorubicin—sarcoma	0.0006	0.00135	CcSEcCtD
Cilazapril—Dermatitis—Thiotepa—sarcoma	0.0006	0.00135	CcSEcCtD
Cilazapril—Headache—Thiotepa—sarcoma	0.000597	0.00134	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000596	0.00134	CcSEcCtD
Cilazapril—Rash—Dactinomycin—sarcoma	0.000596	0.00134	CcSEcCtD
Cilazapril—Decreased appetite—Etoposide—sarcoma	0.000595	0.00133	CcSEcCtD
Cilazapril—Renal failure—Epirubicin—sarcoma	0.000591	0.00133	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Etoposide—sarcoma	0.000591	0.00132	CcSEcCtD
Cilazapril—Asthenia—Mitoxantrone—sarcoma	0.00059	0.00132	CcSEcCtD
Cilazapril—Fatigue—Etoposide—sarcoma	0.00059	0.00132	CcSEcCtD
Cilazapril—Pain—Etoposide—sarcoma	0.000585	0.00131	CcSEcCtD
Cilazapril—Constipation—Etoposide—sarcoma	0.000585	0.00131	CcSEcCtD
Cilazapril—Conjunctivitis—Epirubicin—sarcoma	0.000585	0.00131	CcSEcCtD
Cilazapril—Neutropenia—Doxorubicin—sarcoma	0.000584	0.00131	CcSEcCtD
Cilazapril—Dysuria—Doxorubicin—sarcoma	0.000584	0.00131	CcSEcCtD
Cilazapril—Diarrhoea—Vincristine—sarcoma	0.000578	0.0013	CcSEcCtD
Cilazapril—Pollakiuria—Doxorubicin—sarcoma	0.000577	0.00129	CcSEcCtD
Cilazapril—Photosensitivity reaction—Doxorubicin—sarcoma	0.00057	0.00128	CcSEcCtD
Cilazapril—Hepatobiliary disease—Epirubicin—sarcoma	0.000569	0.00128	CcSEcCtD
Cilazapril—Epistaxis—Epirubicin—sarcoma	0.000567	0.00127	CcSEcCtD
Cilazapril—Nausea—Thiotepa—sarcoma	0.000566	0.00127	CcSEcCtD
Cilazapril—Sinusitis—Epirubicin—sarcoma	0.000564	0.00127	CcSEcCtD
Cilazapril—Feeling abnormal—Etoposide—sarcoma	0.000564	0.00126	CcSEcCtD
Cilazapril—Hyperglycaemia—Doxorubicin—sarcoma	0.000563	0.00126	CcSEcCtD
Cilazapril—Diarrhoea—Mitoxantrone—sarcoma	0.000563	0.00126	CcSEcCtD
Cilazapril—Nausea—Dactinomycin—sarcoma	0.000562	0.00126	CcSEcCtD
Cilazapril—Agranulocytosis—Epirubicin—sarcoma	0.000561	0.00126	CcSEcCtD
Cilazapril—Gastrointestinal pain—Etoposide—sarcoma	0.00056	0.00125	CcSEcCtD
Cilazapril—Dizziness—Vincristine—sarcoma	0.000559	0.00125	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000552	0.00124	CcSEcCtD
Cilazapril—Bradycardia—Epirubicin—sarcoma	0.00055	0.00123	CcSEcCtD
Cilazapril—Renal failure—Doxorubicin—sarcoma	0.000547	0.00123	CcSEcCtD
Cilazapril—Urticaria—Etoposide—sarcoma	0.000544	0.00122	CcSEcCtD
Cilazapril—Rhinitis—Epirubicin—sarcoma	0.000541	0.00121	CcSEcCtD
Cilazapril—Abdominal pain—Etoposide—sarcoma	0.000541	0.00121	CcSEcCtD
Cilazapril—Conjunctivitis—Doxorubicin—sarcoma	0.000541	0.00121	CcSEcCtD
Cilazapril—Hypoaesthesia—Epirubicin—sarcoma	0.000537	0.0012	CcSEcCtD
Cilazapril—Vomiting—Vincristine—sarcoma	0.000537	0.0012	CcSEcCtD
Cilazapril—Pharyngitis—Epirubicin—sarcoma	0.000536	0.0012	CcSEcCtD
Cilazapril—Urinary tract disorder—Epirubicin—sarcoma	0.000533	0.0012	CcSEcCtD
Cilazapril—Rash—Vincristine—sarcoma	0.000533	0.00119	CcSEcCtD
Cilazapril—Dermatitis—Vincristine—sarcoma	0.000532	0.00119	CcSEcCtD
Cilazapril—Urethral disorder—Epirubicin—sarcoma	0.000529	0.00119	CcSEcCtD
Cilazapril—Headache—Vincristine—sarcoma	0.000529	0.00119	CcSEcCtD
Cilazapril—ABCB1—lymph node—sarcoma	0.000529	0.00268	CbGeAlD
Cilazapril—Hepatobiliary disease—Doxorubicin—sarcoma	0.000526	0.00118	CcSEcCtD
Cilazapril—Epistaxis—Doxorubicin—sarcoma	0.000525	0.00118	CcSEcCtD
Cilazapril—Vomiting—Mitoxantrone—sarcoma	0.000523	0.00117	CcSEcCtD
Cilazapril—Sinusitis—Doxorubicin—sarcoma	0.000522	0.00117	CcSEcCtD
Cilazapril—Visual impairment—Epirubicin—sarcoma	0.00052	0.00117	CcSEcCtD
Cilazapril—Agranulocytosis—Doxorubicin—sarcoma	0.000519	0.00116	CcSEcCtD
Cilazapril—Rash—Mitoxantrone—sarcoma	0.000519	0.00116	CcSEcCtD
Cilazapril—Dermatitis—Mitoxantrone—sarcoma	0.000518	0.00116	CcSEcCtD
Cilazapril—Headache—Mitoxantrone—sarcoma	0.000515	0.00116	CcSEcCtD
Cilazapril—Erythema multiforme—Epirubicin—sarcoma	0.00051	0.00114	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—sarcoma	0.000509	0.00114	CcSEcCtD
Cilazapril—Hypersensitivity—Etoposide—sarcoma	0.000504	0.00113	CcSEcCtD
Cilazapril—Tinnitus—Epirubicin—sarcoma	0.000503	0.00113	CcSEcCtD
Cilazapril—Nausea—Vincristine—sarcoma	0.000502	0.00113	CcSEcCtD
Cilazapril—Cardiac disorder—Epirubicin—sarcoma	0.000501	0.00112	CcSEcCtD
Cilazapril—Flushing—Epirubicin—sarcoma	0.000501	0.00112	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—sarcoma	0.000501	0.00112	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—sarcoma	0.000497	0.00111	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—sarcoma	0.000496	0.00111	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—sarcoma	0.000493	0.00111	CcSEcCtD
Cilazapril—Asthenia—Etoposide—sarcoma	0.000491	0.0011	CcSEcCtD
Cilazapril—Angiopathy—Epirubicin—sarcoma	0.00049	0.0011	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—sarcoma	0.00049	0.0011	CcSEcCtD
Cilazapril—Nausea—Mitoxantrone—sarcoma	0.000489	0.0011	CcSEcCtD
Cilazapril—Immune system disorder—Epirubicin—sarcoma	0.000488	0.00109	CcSEcCtD
Cilazapril—Chills—Epirubicin—sarcoma	0.000484	0.00109	CcSEcCtD
Cilazapril—Pruritus—Etoposide—sarcoma	0.000484	0.00109	CcSEcCtD
Cilazapril—Arrhythmia—Epirubicin—sarcoma	0.000482	0.00108	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—sarcoma	0.000481	0.00108	CcSEcCtD
Cilazapril—Alopecia—Epirubicin—sarcoma	0.000477	0.00107	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—sarcoma	0.000472	0.00106	CcSEcCtD
Cilazapril—Diarrhoea—Etoposide—sarcoma	0.000468	0.00105	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—sarcoma	0.000466	0.00104	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—sarcoma	0.000464	0.00104	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—sarcoma	0.000464	0.00104	CcSEcCtD
Cilazapril—Flatulence—Epirubicin—sarcoma	0.000463	0.00104	CcSEcCtD
Cilazapril—Tension—Epirubicin—sarcoma	0.000461	0.00103	CcSEcCtD
Cilazapril—Dysgeusia—Epirubicin—sarcoma	0.00046	0.00103	CcSEcCtD
Cilazapril—Nervousness—Epirubicin—sarcoma	0.000456	0.00102	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—sarcoma	0.000453	0.00102	CcSEcCtD
Cilazapril—Dizziness—Etoposide—sarcoma	0.000452	0.00101	CcSEcCtD
Cilazapril—Muscle spasms—Epirubicin—sarcoma	0.000452	0.00101	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—sarcoma	0.000451	0.00101	CcSEcCtD
Cilazapril—Chills—Doxorubicin—sarcoma	0.000448	0.00101	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—sarcoma	0.000446	0.001	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—sarcoma	0.000441	0.00099	CcSEcCtD
Cilazapril—Ill-defined disorder—Epirubicin—sarcoma	0.000436	0.000978	CcSEcCtD
Cilazapril—Vomiting—Etoposide—sarcoma	0.000435	0.000976	CcSEcCtD
Cilazapril—Anaemia—Epirubicin—sarcoma	0.000434	0.000974	CcSEcCtD
Cilazapril—Rash—Etoposide—sarcoma	0.000431	0.000968	CcSEcCtD
Cilazapril—Dermatitis—Etoposide—sarcoma	0.000431	0.000967	CcSEcCtD
Cilazapril—Headache—Etoposide—sarcoma	0.000429	0.000961	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—sarcoma	0.000428	0.000961	CcSEcCtD
Cilazapril—Tension—Doxorubicin—sarcoma	0.000427	0.000957	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—sarcoma	0.000426	0.000955	CcSEcCtD
Cilazapril—Malaise—Epirubicin—sarcoma	0.000424	0.000951	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—sarcoma	0.000422	0.000947	CcSEcCtD
Cilazapril—Vertigo—Epirubicin—sarcoma	0.000422	0.000947	CcSEcCtD
Cilazapril—Syncope—Epirubicin—sarcoma	0.000421	0.000945	CcSEcCtD
Cilazapril—Leukopenia—Epirubicin—sarcoma	0.000421	0.000943	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—sarcoma	0.000418	0.000938	CcSEcCtD
Cilazapril—Palpitations—Epirubicin—sarcoma	0.000415	0.000931	CcSEcCtD
Cilazapril—Loss of consciousness—Epirubicin—sarcoma	0.000413	0.000926	CcSEcCtD
Cilazapril—Cough—Epirubicin—sarcoma	0.00041	0.00092	CcSEcCtD
Cilazapril—Nausea—Etoposide—sarcoma	0.000406	0.000912	CcSEcCtD
Cilazapril—Hypertension—Epirubicin—sarcoma	0.000406	0.00091	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—sarcoma	0.000403	0.000905	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—sarcoma	0.000402	0.000901	CcSEcCtD
Cilazapril—Myalgia—Epirubicin—sarcoma	0.0004	0.000897	CcSEcCtD
Cilazapril—Chest pain—Epirubicin—sarcoma	0.0004	0.000897	CcSEcCtD
Cilazapril—Arthralgia—Epirubicin—sarcoma	0.0004	0.000897	CcSEcCtD
Cilazapril—Anxiety—Epirubicin—sarcoma	0.000399	0.000894	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000397	0.000891	CcSEcCtD
Cilazapril—Discomfort—Epirubicin—sarcoma	0.000395	0.000887	CcSEcCtD
Cilazapril—Malaise—Doxorubicin—sarcoma	0.000392	0.000879	CcSEcCtD
Cilazapril—Dry mouth—Epirubicin—sarcoma	0.000391	0.000878	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—sarcoma	0.000391	0.000876	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—sarcoma	0.00039	0.000875	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—sarcoma	0.000389	0.000873	CcSEcCtD
Cilazapril—Confusional state—Epirubicin—sarcoma	0.000387	0.000867	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—sarcoma	0.000384	0.000862	CcSEcCtD
Cilazapril—Oedema—Epirubicin—sarcoma	0.000384	0.00086	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—sarcoma	0.000382	0.000857	CcSEcCtD
Cilazapril—Cough—Doxorubicin—sarcoma	0.000379	0.000851	CcSEcCtD
Cilazapril—Shock—Epirubicin—sarcoma	0.000377	0.000846	CcSEcCtD
Cilazapril—Thrombocytopenia—Epirubicin—sarcoma	0.000376	0.000842	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—sarcoma	0.000375	0.000842	CcSEcCtD
Cilazapril—Tachycardia—Epirubicin—sarcoma	0.000374	0.00084	CcSEcCtD
Cilazapril—Skin disorder—Epirubicin—sarcoma	0.000373	0.000836	CcSEcCtD
Cilazapril—Hyperhidrosis—Epirubicin—sarcoma	0.000371	0.000832	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—sarcoma	0.00037	0.00083	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—sarcoma	0.00037	0.00083	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—sarcoma	0.00037	0.00083	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—sarcoma	0.000369	0.000827	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000368	0.000825	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—sarcoma	0.000366	0.00082	CcSEcCtD
Cilazapril—Anorexia—Epirubicin—sarcoma	0.000366	0.00082	CcSEcCtD
Cilazapril—Dry mouth—Doxorubicin—sarcoma	0.000362	0.000812	CcSEcCtD
Cilazapril—Hypotension—Epirubicin—sarcoma	0.000358	0.000804	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—sarcoma	0.000358	0.000803	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—sarcoma	0.000355	0.000796	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000349	0.000784	CcSEcCtD
Cilazapril—Shock—Doxorubicin—sarcoma	0.000349	0.000783	CcSEcCtD
Cilazapril—Thrombocytopenia—Doxorubicin—sarcoma	0.000347	0.000779	CcSEcCtD
Cilazapril—Insomnia—Epirubicin—sarcoma	0.000347	0.000778	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—sarcoma	0.000346	0.000777	CcSEcCtD
Cilazapril—Skin disorder—Doxorubicin—sarcoma	0.000345	0.000773	CcSEcCtD
Cilazapril—Paraesthesia—Epirubicin—sarcoma	0.000344	0.000772	CcSEcCtD
Cilazapril—Hyperhidrosis—Doxorubicin—sarcoma	0.000343	0.000769	CcSEcCtD
Cilazapril—Dyspnoea—Epirubicin—sarcoma	0.000342	0.000767	CcSEcCtD
Cilazapril—Somnolence—Epirubicin—sarcoma	0.000341	0.000765	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—sarcoma	0.000338	0.000759	CcSEcCtD
Cilazapril—Dyspepsia—Epirubicin—sarcoma	0.000338	0.000757	CcSEcCtD
Cilazapril—Decreased appetite—Epirubicin—sarcoma	0.000333	0.000748	CcSEcCtD
Cilazapril—Hypotension—Doxorubicin—sarcoma	0.000332	0.000744	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Epirubicin—sarcoma	0.000331	0.000743	CcSEcCtD
Cilazapril—Fatigue—Epirubicin—sarcoma	0.000331	0.000742	CcSEcCtD
Cilazapril—Constipation—Epirubicin—sarcoma	0.000328	0.000736	CcSEcCtD
Cilazapril—Pain—Epirubicin—sarcoma	0.000328	0.000736	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000323	0.000725	CcSEcCtD
Cilazapril—Insomnia—Doxorubicin—sarcoma	0.000321	0.00072	CcSEcCtD
Cilazapril—Paraesthesia—Doxorubicin—sarcoma	0.000319	0.000715	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—sarcoma	0.000316	0.00071	CcSEcCtD
Cilazapril—Feeling abnormal—Epirubicin—sarcoma	0.000316	0.000709	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—sarcoma	0.000315	0.000708	CcSEcCtD
Cilazapril—Gastrointestinal pain—Epirubicin—sarcoma	0.000314	0.000703	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—sarcoma	0.000312	0.000701	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—sarcoma	0.000309	0.000692	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000306	0.000687	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—sarcoma	0.000306	0.000686	CcSEcCtD
Cilazapril—Urticaria—Epirubicin—sarcoma	0.000305	0.000683	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—sarcoma	0.000303	0.000681	CcSEcCtD
Cilazapril—Pain—Doxorubicin—sarcoma	0.000303	0.000681	CcSEcCtD
Cilazapril—Abdominal pain—Epirubicin—sarcoma	0.000303	0.00068	CcSEcCtD
Cilazapril—Feeling abnormal—Doxorubicin—sarcoma	0.000292	0.000656	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—sarcoma	0.00029	0.000651	CcSEcCtD
Cilazapril—Hypersensitivity—Epirubicin—sarcoma	0.000283	0.000634	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—sarcoma	0.000282	0.000632	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—sarcoma	0.000281	0.000629	CcSEcCtD
Cilazapril—Asthenia—Epirubicin—sarcoma	0.000275	0.000617	CcSEcCtD
Cilazapril—Pruritus—Epirubicin—sarcoma	0.000271	0.000609	CcSEcCtD
Cilazapril—Diarrhoea—Epirubicin—sarcoma	0.000262	0.000589	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—sarcoma	0.000261	0.000586	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—sarcoma	0.000255	0.000571	CcSEcCtD
Cilazapril—Dizziness—Epirubicin—sarcoma	0.000254	0.000569	CcSEcCtD
Cilazapril—Pruritus—Doxorubicin—sarcoma	0.000251	0.000563	CcSEcCtD
Cilazapril—Vomiting—Epirubicin—sarcoma	0.000244	0.000547	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—sarcoma	0.000243	0.000545	CcSEcCtD
Cilazapril—Rash—Epirubicin—sarcoma	0.000242	0.000542	CcSEcCtD
Cilazapril—Dermatitis—Epirubicin—sarcoma	0.000242	0.000542	CcSEcCtD
Cilazapril—Headache—Epirubicin—sarcoma	0.00024	0.000539	CcSEcCtD
Cilazapril—Dizziness—Doxorubicin—sarcoma	0.000235	0.000526	CcSEcCtD
Cilazapril—Nausea—Epirubicin—sarcoma	0.000228	0.000511	CcSEcCtD
Cilazapril—Vomiting—Doxorubicin—sarcoma	0.000226	0.000506	CcSEcCtD
Cilazapril—Rash—Doxorubicin—sarcoma	0.000224	0.000502	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—sarcoma	0.000224	0.000501	CcSEcCtD
Cilazapril—Headache—Doxorubicin—sarcoma	0.000222	0.000499	CcSEcCtD
Cilazapril—Nausea—Doxorubicin—sarcoma	0.000211	0.000473	CcSEcCtD
